CN114402064A - 红色诺卡氏菌细胞壁骨架在再生医学中的用途 - Google Patents

红色诺卡氏菌细胞壁骨架在再生医学中的用途 Download PDF

Info

Publication number
CN114402064A
CN114402064A CN202180005356.2A CN202180005356A CN114402064A CN 114402064 A CN114402064 A CN 114402064A CN 202180005356 A CN202180005356 A CN 202180005356A CN 114402064 A CN114402064 A CN 114402064A
Authority
CN
China
Prior art keywords
stem cells
mesenchymal stem
cell wall
nocardia rubra
product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202180005356.2A
Other languages
English (en)
Inventor
盖波
窦春艳
金培生
张轶
张国英
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Liaoning Greatest Bio Pharmaceutical Co Ltd
Original Assignee
Liaoning Greatest Bio Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Liaoning Greatest Bio Pharmaceutical Co Ltd filed Critical Liaoning Greatest Bio Pharmaceutical Co Ltd
Priority to CN202410358407.5A priority Critical patent/CN118028228A/zh
Publication of CN114402064A publication Critical patent/CN114402064A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0667—Adipose-derived stem cells [ADSC]; Adipose stromal stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/70—Undefined extracts
    • C12N2500/72—Undefined extracts from bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

本公开涉及红色诺卡氏菌细胞壁骨架在再生医学中的用途。具体而言，涉及红色诺卡氏菌(尤其是其细胞壁骨架)在以下方面的用途：促进干细胞的增殖、促进干细胞的生长、促进干细胞的分化、促进干细胞的迁移、提高干细胞的存活率；其中所述干细胞选自：成体干细胞、iPSC、间充质干细胞。

Description

PCT国内申请，说明书已公开。

Claims (10)

  1. PCT国内申请，权利要求书已公开。
CN202180005356.2A 2020-01-21 2021-01-20 红色诺卡氏菌细胞壁骨架在再生医学中的用途 Pending CN114402064A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202410358407.5A CN118028228A (zh) 2020-01-21 2021-01-20 红色诺卡氏菌细胞壁骨架在再生医学中的用途

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN2020100680706 2020-01-21
CN202010068070 2020-01-21
PCT/CN2021/072874 WO2021147900A1 (zh) 2020-01-21 2021-01-20 红色诺卡氏菌细胞壁骨架在再生医学中的用途

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN202410358407.5A Division CN118028228A (zh) 2020-01-21 2021-01-20 红色诺卡氏菌细胞壁骨架在再生医学中的用途

Publications (1)

Publication Number Publication Date
CN114402064A true CN114402064A (zh) 2022-04-26

Family

ID=76992066

Family Applications (2)

Application Number Title Priority Date Filing Date
CN202180005356.2A Pending CN114402064A (zh) 2020-01-21 2021-01-20 红色诺卡氏菌细胞壁骨架在再生医学中的用途
CN202410358407.5A Pending CN118028228A (zh) 2020-01-21 2021-01-20 红色诺卡氏菌细胞壁骨架在再生医学中的用途

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN202410358407.5A Pending CN118028228A (zh) 2020-01-21 2021-01-20 红色诺卡氏菌细胞壁骨架在再生医学中的用途

Country Status (6)

Country Link
US (1) US20230071748A1 (zh)
EP (1) EP4056682A4 (zh)
JP (1) JP2023512460A (zh)
KR (1) KR20220130163A (zh)
CN (2) CN114402064A (zh)
WO (1) WO2021147900A1 (zh)

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1443542A (zh) * 2002-03-08 2003-09-24 沈阳胜宝康生物制药有限公司 红色诺卡放线菌细胞壁骨架制剂
CN102526119A (zh) * 2010-12-23 2012-07-04 辽宁纳可佳生物制药有限公司 红色诺卡氏菌细胞壁骨架增强树突状细胞功能的方法
CN103169734A (zh) * 2013-03-26 2013-06-26 福建省微生物研究所 红色诺卡氏菌细胞壁骨架的新用途
CN108795859A (zh) * 2017-05-03 2018-11-13 辽宁格瑞仕特生物制药有限公司 红色诺卡氏菌细胞壁骨架作为自然杀伤细胞增殖促进剂的用途
CN108795860A (zh) * 2017-05-03 2018-11-13 辽宁格瑞仕特生物制药有限公司 红色诺卡氏菌细胞壁骨架作为cd8+t细胞增殖促进剂的用途
CN108815197A (zh) * 2017-05-03 2018-11-16 辽宁格瑞仕特生物制药有限公司 红色诺卡氏菌细胞壁骨架作为cd4+t细胞增殖促进剂的用途
CN108815198A (zh) * 2017-05-03 2018-11-16 辽宁格瑞仕特生物制药有限公司 红色诺卡氏菌细胞壁骨架作为巨噬细胞增殖促进剂的用途
CN111359010A (zh) * 2020-05-20 2020-07-03 高尚先 用于修复皮肤损伤的干细胞凝胶前体组合物、其组织工程组合物使用盒及应用
CN112040962A (zh) * 2019-03-14 2020-12-04 辽宁格瑞仕特生物制药有限公司 红色诺卡氏菌细胞壁骨架在治疗外阴白色病变中的用途

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1094288A (zh) * 1993-04-23 1994-11-02 福建省微生物研究所 利用红色诺卡氏菌制造细胞壁骨架粉末的方法
CN1879661B (zh) 2005-06-16 2012-06-20 辽宁纳可佳生物制药有限公司 红色诺卡氏菌细胞壁骨架在制备抗真菌感染的药物中的用途
CN1935262B (zh) 2005-09-23 2010-12-29 沈阳胜宝康生物制药有限公司 红色诺卡氏菌细胞壁骨架在制备抗人乳头瘤病毒药物的用途
CN101073583A (zh) 2006-05-19 2007-11-21 沈阳胜宝康生物制药有限公司 红色诺卡氏菌细胞壁骨架在制备药物中的用途
CN101209267B (zh) 2006-12-29 2012-10-03 辽宁纳可佳生物制药有限公司 红色诺卡氏菌细胞壁骨架在制备治疗皮肤损伤和疮疡的药物中的用途
CN101250490A (zh) 2008-03-28 2008-08-27 天津科技大学 活酵母细胞衍生物的生产方法
CN101323865B (zh) 2008-08-07 2012-07-18 山东省科学院能源研究所 微生物油脂分离提取方法
CN108295095A (zh) 2017-01-11 2018-07-20 福建省山河药业有限公司 红色诺卡氏菌细胞壁骨架在制备治疗痤疮的药物/护肤品中的用途及其药物/护肤品组合物
CN108938674A (zh) 2017-05-27 2018-12-07 福建省山河药业有限公司 红色诺卡氏菌细胞壁骨架在制备治疗皮肤病变药物中的用途
CN111683670A (zh) * 2019-01-09 2020-09-18 辽宁格瑞仕特生物制药有限公司 红色诺卡氏菌细胞壁骨架在治疗复发性阿弗他溃疡中的用途

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1443542A (zh) * 2002-03-08 2003-09-24 沈阳胜宝康生物制药有限公司 红色诺卡放线菌细胞壁骨架制剂
CN102526119A (zh) * 2010-12-23 2012-07-04 辽宁纳可佳生物制药有限公司 红色诺卡氏菌细胞壁骨架增强树突状细胞功能的方法
CN103169734A (zh) * 2013-03-26 2013-06-26 福建省微生物研究所 红色诺卡氏菌细胞壁骨架的新用途
CN108795859A (zh) * 2017-05-03 2018-11-13 辽宁格瑞仕特生物制药有限公司 红色诺卡氏菌细胞壁骨架作为自然杀伤细胞增殖促进剂的用途
CN108795860A (zh) * 2017-05-03 2018-11-13 辽宁格瑞仕特生物制药有限公司 红色诺卡氏菌细胞壁骨架作为cd8+t细胞增殖促进剂的用途
CN108815197A (zh) * 2017-05-03 2018-11-16 辽宁格瑞仕特生物制药有限公司 红色诺卡氏菌细胞壁骨架作为cd4+t细胞增殖促进剂的用途
CN108815198A (zh) * 2017-05-03 2018-11-16 辽宁格瑞仕特生物制药有限公司 红色诺卡氏菌细胞壁骨架作为巨噬细胞增殖促进剂的用途
CN112040962A (zh) * 2019-03-14 2020-12-04 辽宁格瑞仕特生物制药有限公司 红色诺卡氏菌细胞壁骨架在治疗外阴白色病变中的用途
CN111359010A (zh) * 2020-05-20 2020-07-03 高尚先 用于修复皮肤损伤的干细胞凝胶前体组合物、其组织工程组合物使用盒及应用

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ELEUTERIO LOMBARDO等: "Toll-like receptor-mediated signaling in human adipose-derived stem cells: implications for immunogenicity and immunosuppressive potential", TISSUE ENG PART A., vol. 15, no. 7, pages 1579 - 89, XP055830897, DOI: 10.1089/ten.tea.2008.0340 *
苏亚楠等: "TLR2配体肽聚糖对骨髓间充质干细胞增殖和细胞周期的影响", 中国实验血液学杂志, vol. 18, no. 4, pages 986 - 990 *
黄文伟: "红色诺卡氏菌发酵罐工艺及其抗肿瘤药理学进一步研究", 中国优秀硕士学位论文全文数据库, no. 08, pages 016 - 432 *

Also Published As

Publication number Publication date
WO2021147900A1 (zh) 2021-07-29
EP4056682A4 (en) 2023-01-18
JP2023512460A (ja) 2023-03-27
KR20220130163A (ko) 2022-09-26
EP4056682A1 (en) 2022-09-14
CN118028228A (zh) 2024-05-14
US20230071748A1 (en) 2023-03-09

Similar Documents

Publication Publication Date Title
CN111727235B (zh) 赤红球菌产品及其制药用途
CN109745341B (zh) 四氧化三铁超顺磁性纳米颗粒刺激干细胞外泌体成骨
CN112121063B (zh) 外泌体在制备治疗肺纤维化的药物中的应用
CN111971054B (zh) 赤红球菌产品在治疗外阴白色病变中的用途
US12064458B2 (en) Use of Rhodococcus ruber product in treating thermal injury
WO2024027673A1 (zh) 红色诺卡氏菌细胞壁骨架在治疗慢性宫颈炎中的应用
CN115087729B (zh) 赤红球菌细胞壁骨架在再生医学中的用途
CN114402064A (zh) 红色诺卡氏菌细胞壁骨架在再生医学中的用途
CN116196334A (zh) 间充质干细胞来源小细胞外囊泡在制备治疗糖尿病视网膜病变的药物中的应用
WO2022199453A1 (zh) 赤红球菌产品在治疗放射病中的用途
CN115025128A (zh) 红色诺卡氏菌细胞壁骨架在治疗宫颈病变中的应用
CN117210395A (zh) 红色诺卡氏菌细胞壁骨架在皮瓣移植术中的用途
US20130230494A1 (en) Cellular Preparations For Wound Management
TWI818466B (zh) 用於治療砷誘發之肺功能損傷之類黃酮藥物
CN118141837A (zh) 红色诺卡氏菌细胞壁骨架在提高脂肪移植物存活率中的用途
CN118178379A (zh) 三亚油酸甘油酯在预防和治疗AhR-Nrf2信号通路介导的相关疾病药物中的应用

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40063808

Country of ref document: HK

CB02 Change of applicant information
CB02 Change of applicant information

Address after: No.1, floor 1, building 8-2, Chun'an street, Shiqiaozi, Xihu District, Benxi City, Liaoning Province

Applicant after: Liaoning Tian'an Biopharmaceutical Co.,Ltd.

Address before: No.1, floor 1, building 8-2, Chun'an street, Shiqiaozi, Xihu District, Benxi City, Liaoning Province

Applicant before: LIAONING GREATEST BIO-PHARMACEUTICAL Co.,Ltd.